Idenix Pharmaceuticals (IDIX) says the USPTO's Patent Trial and Appeal Board has decided against...

|About: Idenix Pharmaceuticals, Inc. (IDIX)|By:, SA News Editor

Idenix Pharmaceuticals (IDIX) says the USPTO's Patent Trial and Appeal Board has decided against it in the first phase of its two-stage interference process concerning one of IDIX's patent applications, and an issued patent owned by Gilead Pharmasset (GILD) that covers certain 2'-methyl- 2'-fluoro nucleoside compounds useful in the treatment of the hepatitis C virus. Shares -13% AH.